chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 38.0
Sex: M
Vaccine: SMALL, TYP, SMALL, TYP
Symptoms: Activated partial thromboplastin time shortened, Anxiety, Blood creatine phosphokinase increased, Blood glucose increased, Chest X-ray normal
Clinical narrative: This case was received on 13 August 2009 via a QScan search on the VAERS database, under reference # 346405. A 38 year old male patient received ACAM2000 (lot number VV04-003A) and TYPHIM VI (lot number B0242) on 13 January 2009. Twenty one days after vaccination the patient complained of substernal chest pain, palpitations at rest, jaw pain, chest tightness and feeling anxious. The patient was hospitalized (dates of admission and discharge not provided). Medical records from 21 January 2009 through 3 February 2009 report that the palpitations had resolved. Troponin I (performed 15 January 2009) was normal. An electrocardiogram (performed 15 January 2009) was abnormal. The records also include a normal electrocardiogram however a date was not provided for this test. The following are additional laboratory results noted from the record: chest x-ray, normal; WBC, increased; creatine phosphokinase, increased; aPTT, shortened; neutrophil count, increased; blood glucose, increased; and single photon emission computerised tomogram, abnormal. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. List of documents held by sender: None.
Age: 38.0
Sex: M
Vaccine: SMALL, TYP, SMALL, TYP
Symptoms: Chest discomfort, Chest pain, Computerised tomogram abnormal, Electrocardiogram abnormal, Neutrophil count increased
Clinical narrative: This case was received on 13 August 2009 via a QScan search on the VAERS database, under reference # 346405. A 38 year old male patient received ACAM2000 (lot number VV04-003A) and TYPHIM VI (lot number B0242) on 13 January 2009. Twenty one days after vaccination the patient complained of substernal chest pain, palpitations at rest, jaw pain, chest tightness and feeling anxious. The patient was hospitalized (dates of admission and discharge not provided). Medical records from 21 January 2009 through 3 February 2009 report that the palpitations had resolved. Troponin I (performed 15 January 2009) was normal. An electrocardiogram (performed 15 January 2009) was abnormal. The records also include a normal electrocardiogram however a date was not provided for this test. The following are additional laboratory results noted from the record: chest x-ray, normal; WBC, increased; creatine phosphokinase, increased; aPTT, shortened; neutrophil count, increased; blood glucose, increased; and single photon emission computerised tomogram, abnormal. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. List of documents held by sender: None.
Age: 38.0
Sex: M
Vaccine: SMALL, TYP, SMALL, TYP
Symptoms: Pain in jaw, Palpitations, Troponin I, White blood cell count increased
Clinical narrative: This case was received on 13 August 2009 via a QScan search on the VAERS database, under reference # 346405. A 38 year old male patient received ACAM2000 (lot number VV04-003A) and TYPHIM VI (lot number B0242) on 13 January 2009. Twenty one days after vaccination the patient complained of substernal chest pain, palpitations at rest, jaw pain, chest tightness and feeling anxious. The patient was hospitalized (dates of admission and discharge not provided). Medical records from 21 January 2009 through 3 February 2009 report that the palpitations had resolved. Troponin I (performed 15 January 2009) was normal. An electrocardiogram (performed 15 January 2009) was abnormal. The records also include a normal electrocardiogram however a date was not provided for this test. The following are additional laboratory results noted from the record: chest x-ray, normal; WBC, increased; creatine phosphokinase, increased; aPTT, shortened; neutrophil count, increased; blood glucose, increased; and single photon emission computerised tomogram, abnormal. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. List of documents held by sender: None.
Age: 37.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Cardiac enzymes normal, Chest X-ray normal, Electrocardiogram normal, Full blood count abnormal, Lymphocyte count increased
Clinical narrative: This case was received on 13 August 2009 via a QScan search, under reference number 346417. A 37 year old male patient received ACAM2000, lot number W04003A on 29 April 2009. Five days after vaccination, the patient developed generalized vaccinia with a diffuse rash, fever and myalgias. A robust take was also reported. The patient was treated with INDOCIN and BENADRYL. Electrocardiogram and cardiac enzymes were normal. Chest X-ray was normal. A complete blood count showed an elevated lymphocyte count. The patient recovered. NOTE: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. List of documents held by sender: none.
Age: 37.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Myalgia, Pyrexia, Rash, Vaccinia
Clinical narrative: This case was received on 13 August 2009 via a QScan search, under reference number 346417. A 37 year old male patient received ACAM2000, lot number W04003A on 29 April 2009. Five days after vaccination, the patient developed generalized vaccinia with a diffuse rash, fever and myalgias. A robust take was also reported. The patient was treated with INDOCIN and BENADRYL. Electrocardiogram and cardiac enzymes were normal. Chest X-ray was normal. A complete blood count showed an elevated lymphocyte count. The patient recovered. NOTE: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. List of documents held by sender: none.
Age: 37.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Cardiac enzymes normal, Chest X-ray normal, Electrocardiogram normal, Full blood count abnormal, Generalised vaccinia
Clinical narrative: This case was received on 13 August 2009 via a QScan search, under reference number 346417. A 37 year old male patient received ACAM2000, lot number W04003A on 29 April 2009. Five days after vaccination, the patient developed generalized vaccinia with a diffuse rash, fever and myalgias. A robust take was also reported. The patient was treated with INDOCIN and BENADRYL. Electrocardiogram and cardiac enzymes were normal. Chest X-ray was normal. A complete blood count showed an elevated lymphocyte count. The patient recovered. NOTE: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. List of documents held by sender: none.
Age: 37.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Lymphocyte count increased, Myalgia, Pyrexia, Rash, Robust take following exposure to vaccinia virus
Clinical narrative: This case was received on 13 August 2009 via a QScan search, under reference number 346417. A 37 year old male patient received ACAM2000, lot number W04003A on 29 April 2009. Five days after vaccination, the patient developed generalized vaccinia with a diffuse rash, fever and myalgias. A robust take was also reported. The patient was treated with INDOCIN and BENADRYL. Electrocardiogram and cardiac enzymes were normal. Chest X-ray was normal. A complete blood count showed an elevated lymphocyte count. The patient recovered. NOTE: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. List of documents held by sender: none.
Age: 19.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Acne, Erythema
Clinical narrative: This case was received on 13 August 2009 via a QScan search on the VAERS database, under reference number 346477.  A 19 year old male received VACCINIA (ACAM2000, lot number W04-003A) on 18 May 2009.  On the day of vaccination, the patient broke out with pimples on his face.  There was also a slight redness.  The patient recovered.  List of documents held by sender:  none.
Age: 41.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Blood creatinine normal, Blood urea normal, Erythema, Induration, Oedema peripheral
Clinical narrative: This case was received on 13 August 2009 via a QScan search on the VAERS database, under reference number 346614. A 41 year old male patient received ACAM2000 (Sanofi Pasteur Biologic Co., lot number VV04-003-A) and anthrax vaccine (manufacturer unknown, lot number FAV164) on 13 May 2009. Five days post vaccination, the patient had left upper arm swelling, redness and warmth. His left thumb base was itching and was painful with motion. Post vaccination the patient sought emergency care with the complaint of his right fourth fingertip being hard and erythema, swelling and purplish discoloration of his right middle finger. The site of smallpox vaccination on the right biceps had erythema an pruritis. Pain and swelling of the left knee was also reported. It was reported that the patient was hospitalized but is unclear what dates of service for the hospitalization or emergency visit occurred. An infectious disease consultation noted whitish pustule on the right arm. The final diagnosis was hand cellulitis; hypertension was noted without diagnostic test results or additional information. Laboratory and diagnostic test results from 19 May 2009 included: white blood cell count: 12.6; Blood urea nitrogen: 10; creatinine: 1.04; (laboratory test units and reference ranges were not provided); Left Upper Extremity Venous ultrasound: slow flow at confluence of left integral joint and left subclavian vein. The outcome of the patient was not reported. No other information was provided. List of documents held by sender: None.
Age: 41.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Pain in extremity, Pruritus, Skin warm, Ultrasound scan abnormal, White blood cell count increased
Clinical narrative: This case was received on 13 August 2009 via a QScan search on the VAERS database, under reference number 346614. A 41 year old male patient received ACAM2000 (Sanofi Pasteur Biologic Co., lot number VV04-003-A) and anthrax vaccine (manufacturer unknown, lot number FAV164) on 13 May 2009. Five days post vaccination, the patient had left upper arm swelling, redness and warmth. His left thumb base was itching and was painful with motion. Post vaccination the patient sought emergency care with the complaint of his right fourth fingertip being hard and erythema, swelling and purplish discoloration of his right middle finger. The site of smallpox vaccination on the right biceps had erythema an pruritis. Pain and swelling of the left knee was also reported. It was reported that the patient was hospitalized but is unclear what dates of service for the hospitalization or emergency visit occurred. An infectious disease consultation noted whitish pustule on the right arm. The final diagnosis was hand cellulitis; hypertension was noted without diagnostic test results or additional information. Laboratory and diagnostic test results from 19 May 2009 included: white blood cell count: 12.6; Blood urea nitrogen: 10; creatinine: 1.04; (laboratory test units and reference ranges were not provided); Left Upper Extremity Venous ultrasound: slow flow at confluence of left integral joint and left subclavian vein. The outcome of the patient was not reported. No other information was provided. List of documents held by sender: None.
Age: 41.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Arthralgia, Blood creatinine normal, Blood urea normal, Cellulitis, Erythema
Clinical narrative: This case was received on 13 August 2009 via a QScan search on the VAERS database, under reference number 346614. A 41 year old male patient received ACAM2000 (Sanofi Pasteur Biologic Co., lot number VV04-003-A) and anthrax vaccine (manufacturer unknown, lot number FAV164) on 13 May 2009. Five days post vaccination, the patient had left upper arm swelling, redness and warmth. His left thumb base was itching and was painful with motion. Post vaccination the patient sought emergency care with the complaint of his right fourth fingertip being hard and erythema, swelling and purplish discoloration of his right middle finger. The site of smallpox vaccination on the right biceps had erythema an pruritis. Pain and swelling of the left knee was also reported. It was reported that the patient was hospitalized but is unclear what dates of service for the hospitalization or emergency visit occurred. An infectious disease consultation noted whitish pustule on the right arm. The final diagnosis was hand cellulitis; hypertension was noted without diagnostic test results or additional information. Laboratory and diagnostic test results from 19 May 2009 included: white blood cell count: 12.6; Blood urea nitrogen: 10; creatinine: 1.04; (laboratory test units and reference ranges were not provided); Left Upper Extremity Venous ultrasound: slow flow at confluence of left integral joint and left subclavian vein. The outcome of the patient was not reported. No other information was provided. List of documents held by sender: None.
Age: 41.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Hypertension, Induration, Injection site erythema, Injection site pruritus, Joint swelling
Clinical narrative: This case was received on 13 August 2009 via a QScan search on the VAERS database, under reference number 346614. A 41 year old male patient received ACAM2000 (Sanofi Pasteur Biologic Co., lot number VV04-003-A) and anthrax vaccine (manufacturer unknown, lot number FAV164) on 13 May 2009. Five days post vaccination, the patient had left upper arm swelling, redness and warmth. His left thumb base was itching and was painful with motion. Post vaccination the patient sought emergency care with the complaint of his right fourth fingertip being hard and erythema, swelling and purplish discoloration of his right middle finger. The site of smallpox vaccination on the right biceps had erythema an pruritis. Pain and swelling of the left knee was also reported. It was reported that the patient was hospitalized but is unclear what dates of service for the hospitalization or emergency visit occurred. An infectious disease consultation noted whitish pustule on the right arm. The final diagnosis was hand cellulitis; hypertension was noted without diagnostic test results or additional information. Laboratory and diagnostic test results from 19 May 2009 included: white blood cell count: 12.6; Blood urea nitrogen: 10; creatinine: 1.04; (laboratory test units and reference ranges were not provided); Left Upper Extremity Venous ultrasound: slow flow at confluence of left integral joint and left subclavian vein. The outcome of the patient was not reported. No other information was provided. List of documents held by sender: None.
Age: 41.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Oedema peripheral, Pain, Pain in extremity, Pruritus, Rash pustular
Clinical narrative: This case was received on 13 August 2009 via a QScan search on the VAERS database, under reference number 346614. A 41 year old male patient received ACAM2000 (Sanofi Pasteur Biologic Co., lot number VV04-003-A) and anthrax vaccine (manufacturer unknown, lot number FAV164) on 13 May 2009. Five days post vaccination, the patient had left upper arm swelling, redness and warmth. His left thumb base was itching and was painful with motion. Post vaccination the patient sought emergency care with the complaint of his right fourth fingertip being hard and erythema, swelling and purplish discoloration of his right middle finger. The site of smallpox vaccination on the right biceps had erythema an pruritis. Pain and swelling of the left knee was also reported. It was reported that the patient was hospitalized but is unclear what dates of service for the hospitalization or emergency visit occurred. An infectious disease consultation noted whitish pustule on the right arm. The final diagnosis was hand cellulitis; hypertension was noted without diagnostic test results or additional information. Laboratory and diagnostic test results from 19 May 2009 included: white blood cell count: 12.6; Blood urea nitrogen: 10; creatinine: 1.04; (laboratory test units and reference ranges were not provided); Left Upper Extremity Venous ultrasound: slow flow at confluence of left integral joint and left subclavian vein. The outcome of the patient was not reported. No other information was provided. List of documents held by sender: None.
Age: 41.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Skin discolouration, Skin warm, Ultrasound scan abnormal, White blood cell count increased
Clinical narrative: This case was received on 13 August 2009 via a QScan search on the VAERS database, under reference number 346614. A 41 year old male patient received ACAM2000 (Sanofi Pasteur Biologic Co., lot number VV04-003-A) and anthrax vaccine (manufacturer unknown, lot number FAV164) on 13 May 2009. Five days post vaccination, the patient had left upper arm swelling, redness and warmth. His left thumb base was itching and was painful with motion. Post vaccination the patient sought emergency care with the complaint of his right fourth fingertip being hard and erythema, swelling and purplish discoloration of his right middle finger. The site of smallpox vaccination on the right biceps had erythema an pruritis. Pain and swelling of the left knee was also reported. It was reported that the patient was hospitalized but is unclear what dates of service for the hospitalization or emergency visit occurred. An infectious disease consultation noted whitish pustule on the right arm. The final diagnosis was hand cellulitis; hypertension was noted without diagnostic test results or additional information. Laboratory and diagnostic test results from 19 May 2009 included: white blood cell count: 12.6; Blood urea nitrogen: 10; creatinine: 1.04; (laboratory test units and reference ranges were not provided); Left Upper Extremity Venous ultrasound: slow flow at confluence of left integral joint and left subclavian vein. The outcome of the patient was not reported. No other information was provided. List of documents held by sender: None.
Age: 21.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Polymerase chain reaction, Secondary transmission, Skin lesion, Vaccinia, Vaginal lesion
Clinical narrative: This case was received on 13 August 20009 via a Qscan search on the database, under reference number 346767. A 21 year old female patient was diagnosed with contact transmission of vaccinia. Her husband received smallpox (vaccinia) vaccine, live (ACAM2000, lot number not reported) around 09 April 2009. On 24 April 2009, the patient develped a lesion near her eye, her arm and multiple lesions in the vaginal area. Cultures and vaccina PCR were obtained. Vacciinia PCR was positive. The patient was givin antiboiotics and pain medications. As of 20 May 2009, the lesions had completely ceared without scarring.  Although the manufacturer was reported as unknown in this case, ACMA2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. List of documents held by sender: none.
Age: 21.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Culture, Infection transmission via personal contact, Polymerase chain reaction, Skin lesion, Vaccinia test positive
Clinical narrative: This case was received on 13 August 20009 via a Qscan search on the database, under reference number 346767. A 21 year old female patient was diagnosed with contact transmission of vaccinia. Her husband received smallpox (vaccinia) vaccine, live (ACAM2000, lot number not reported) around 09 April 2009. On 24 April 2009, the patient develped a lesion near her eye, her arm and multiple lesions in the vaginal area. Cultures and vaccina PCR were obtained. Vacciinia PCR was positive. The patient was givin antiboiotics and pain medications. As of 20 May 2009, the lesions had completely ceared without scarring.  Although the manufacturer was reported as unknown in this case, ACMA2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. List of documents held by sender: none.
Age: 21.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Vaginal lesion
Clinical narrative: This case was received on 13 August 20009 via a Qscan search on the database, under reference number 346767. A 21 year old female patient was diagnosed with contact transmission of vaccinia. Her husband received smallpox (vaccinia) vaccine, live (ACAM2000, lot number not reported) around 09 April 2009. On 24 April 2009, the patient develped a lesion near her eye, her arm and multiple lesions in the vaginal area. Cultures and vaccina PCR were obtained. Vacciinia PCR was positive. The patient was givin antiboiotics and pain medications. As of 20 May 2009, the lesions had completely ceared without scarring.  Although the manufacturer was reported as unknown in this case, ACMA2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. List of documents held by sender: none.
Age: 22.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Blood chloride decreased, Blood creatine phosphokinase MB increased, Blood creatine phosphokinase increased, Blood creatinine increased, Full blood count
Clinical narrative: This case was received on 13 August 2009 via QScan search on the VAERS database, under reference number 346821. A 22 year old male patient received a right deltoid injection of ACAM2000 vaccine, lot number W04-003A on 19 April 2009. Medical records from received for dates of service 27 April 2009 through 01 June 2009 include the following information. Beginning eight days after vaccination, the patient developed the following symptoms: chest pain, sharp pain shooting down the left arm, vomiting, lightheadedness, headache, paroxysmal nocturnal dyspnea, bradycardia, and chest tightness. The patient was hospitalized (dates of admission and discharge not provided). The patient was initially diagnosed with acute myocarditis which was subsequently changed to myocarditis/pericarditis. The following findings were included in the report: troponin, 0.97 (increased); creatine phosphokinase (CK), 445 (increased); CK-MB, 15.3 (increased); myoglobin blood, 228 (increased); electrocardiogram, ST segment elevation; and echocardiogram, normal. Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination and the lot number reported is an ACAM2000 lot number. List of documents held by sender: none.
Age: 22.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Myocarditis, Myoglobin blood increased, Troponin increased
Clinical narrative: This case was received on 13 August 2009 via QScan search on the VAERS database, under reference number 346821. A 22 year old male patient received a right deltoid injection of ACAM2000 vaccine, lot number W04-003A on 19 April 2009. Medical records from received for dates of service 27 April 2009 through 01 June 2009 include the following information. Beginning eight days after vaccination, the patient developed the following symptoms: chest pain, sharp pain shooting down the left arm, vomiting, lightheadedness, headache, paroxysmal nocturnal dyspnea, bradycardia, and chest tightness. The patient was hospitalized (dates of admission and discharge not provided). The patient was initially diagnosed with acute myocarditis which was subsequently changed to myocarditis/pericarditis. The following findings were included in the report: troponin, 0.97 (increased); creatine phosphokinase (CK), 445 (increased); CK-MB, 15.3 (increased); myoglobin blood, 228 (increased); electrocardiogram, ST segment elevation; and echocardiogram, normal. Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination and the lot number reported is an ACAM2000 lot number. List of documents held by sender: none.
Age: 22.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Blood creatine phosphokinase MB increased, Blood creatine phosphokinase increased, Bradycardia, Chest discomfort, Chest pain
Clinical narrative: This case was received on 13 August 2009 via QScan search on the VAERS database, under reference number 346821. A 22 year old male patient received a right deltoid injection of ACAM2000 vaccine, lot number W04-003A on 19 April 2009. Medical records from received for dates of service 27 April 2009 through 01 June 2009 include the following information. Beginning eight days after vaccination, the patient developed the following symptoms: chest pain, sharp pain shooting down the left arm, vomiting, lightheadedness, headache, paroxysmal nocturnal dyspnea, bradycardia, and chest tightness. The patient was hospitalized (dates of admission and discharge not provided). The patient was initially diagnosed with acute myocarditis which was subsequently changed to myocarditis/pericarditis. The following findings were included in the report: troponin, 0.97 (increased); creatine phosphokinase (CK), 445 (increased); CK-MB, 15.3 (increased); myoglobin blood, 228 (increased); electrocardiogram, ST segment elevation; and echocardiogram, normal. Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination and the lot number reported is an ACAM2000 lot number. List of documents held by sender: none.
Age: 22.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Dizziness, Dyspnoea paroxysmal nocturnal, Echocardiogram normal, Electrocardiogram ST segment elevation, Headache
Clinical narrative: This case was received on 13 August 2009 via QScan search on the VAERS database, under reference number 346821. A 22 year old male patient received a right deltoid injection of ACAM2000 vaccine, lot number W04-003A on 19 April 2009. Medical records from received for dates of service 27 April 2009 through 01 June 2009 include the following information. Beginning eight days after vaccination, the patient developed the following symptoms: chest pain, sharp pain shooting down the left arm, vomiting, lightheadedness, headache, paroxysmal nocturnal dyspnea, bradycardia, and chest tightness. The patient was hospitalized (dates of admission and discharge not provided). The patient was initially diagnosed with acute myocarditis which was subsequently changed to myocarditis/pericarditis. The following findings were included in the report: troponin, 0.97 (increased); creatine phosphokinase (CK), 445 (increased); CK-MB, 15.3 (increased); myoglobin blood, 228 (increased); electrocardiogram, ST segment elevation; and echocardiogram, normal. Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination and the lot number reported is an ACAM2000 lot number. List of documents held by sender: none.
Age: 22.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Myocarditis, Myoglobin blood increased, Pain in extremity, Pericarditis, Troponin increased
Clinical narrative: This case was received on 13 August 2009 via QScan search on the VAERS database, under reference number 346821. A 22 year old male patient received a right deltoid injection of ACAM2000 vaccine, lot number W04-003A on 19 April 2009. Medical records from received for dates of service 27 April 2009 through 01 June 2009 include the following information. Beginning eight days after vaccination, the patient developed the following symptoms: chest pain, sharp pain shooting down the left arm, vomiting, lightheadedness, headache, paroxysmal nocturnal dyspnea, bradycardia, and chest tightness. The patient was hospitalized (dates of admission and discharge not provided). The patient was initially diagnosed with acute myocarditis which was subsequently changed to myocarditis/pericarditis. The following findings were included in the report: troponin, 0.97 (increased); creatine phosphokinase (CK), 445 (increased); CK-MB, 15.3 (increased); myoglobin blood, 228 (increased); electrocardiogram, ST segment elevation; and echocardiogram, normal. Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination and the lot number reported is an ACAM2000 lot number. List of documents held by sender: none.
Age: 22.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Vomiting
Clinical narrative: This case was received on 13 August 2009 via QScan search on the VAERS database, under reference number 346821. A 22 year old male patient received a right deltoid injection of ACAM2000 vaccine, lot number W04-003A on 19 April 2009. Medical records from received for dates of service 27 April 2009 through 01 June 2009 include the following information. Beginning eight days after vaccination, the patient developed the following symptoms: chest pain, sharp pain shooting down the left arm, vomiting, lightheadedness, headache, paroxysmal nocturnal dyspnea, bradycardia, and chest tightness. The patient was hospitalized (dates of admission and discharge not provided). The patient was initially diagnosed with acute myocarditis which was subsequently changed to myocarditis/pericarditis. The following findings were included in the report: troponin, 0.97 (increased); creatine phosphokinase (CK), 445 (increased); CK-MB, 15.3 (increased); myoglobin blood, 228 (increased); electrocardiogram, ST segment elevation; and echocardiogram, normal. Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination and the lot number reported is an ACAM2000 lot number. List of documents held by sender: none.
Age: 25.0
Sex: F
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Bundle branch block right, Chest pain, Chills, Dyspnoea, Electrocardiogram abnormal
Clinical narrative: This case was received on 13 August 2009 via a QScan search on the VAERS database, under reference number 347005. A 25 year old female patient received ACAM2000 (Sanofi Pasteur Biologics Co., lot number W04003A) and anthrax vaccine (Emergent Biosolutions, lot number FAV149) on 12 May 2009. Approximately two days after vaccination  the patient developed fever and chills with resolved overnight. The patient went running the next day and experienced chest pain that resolved with walking, but resumed when she returned running. Other reported symptoms included dyspnea and a sensation of a pounding regular heartbeat. The patient presented to an acute care clinic where an electrocardiogram was performed and was significant for incomplete right bundle branch block. The patient was sent to an emergency room for further evaluation. The patient was not hospitalized and recovered.
Age: 25.0
Sex: F
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Exercise electrocardiogram, Palpitations, Pyrexia, Red blood cell sedimentation rate normal, Troponin
Clinical narrative: This case was received on 13 August 2009 via a QScan search on the VAERS database, under reference number 347005. A 25 year old female patient received ACAM2000 (Sanofi Pasteur Biologics Co., lot number W04003A) and anthrax vaccine (Emergent Biosolutions, lot number FAV149) on 12 May 2009. Approximately two days after vaccination  the patient developed fever and chills with resolved overnight. The patient went running the next day and experienced chest pain that resolved with walking, but resumed when she returned running. Other reported symptoms included dyspnea and a sensation of a pounding regular heartbeat. The patient presented to an acute care clinic where an electrocardiogram was performed and was significant for incomplete right bundle branch block. The patient was sent to an emergency room for further evaluation. The patient was not hospitalized and recovered.
Age: 25.0
Sex: F
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Exercise electrocardiogram, Fibrin D dimer, Palpitations, Pyrexia, Red blood cell sedimentation rate
Clinical narrative: This case was received on 13 August 2009 via a QScan search on the VAERS database, under reference number 347005. A 25 year old female patient received ACAM2000 (Sanofi Pasteur Biologics Co., lot number W04003A) and anthrax vaccine (Emergent Biosolutions, lot number FAV149) on 12 May 2009. Approximately two days after vaccination  the patient developed fever and chills with resolved overnight. The patient went running the next day and experienced chest pain that resolved with walking, but resumed when she returned running. Other reported symptoms included dyspnea and a sensation of a pounding regular heartbeat. The patient presented to an acute care clinic where an electrocardiogram was performed and was significant for incomplete right bundle branch block. The patient was sent to an emergency room for further evaluation. The patient was not hospitalized and recovered.
Age: 25.0
Sex: F
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Troponin
Clinical narrative: This case was received on 13 August 2009 via a QScan search on the VAERS database, under reference number 347005. A 25 year old female patient received ACAM2000 (Sanofi Pasteur Biologics Co., lot number W04003A) and anthrax vaccine (Emergent Biosolutions, lot number FAV149) on 12 May 2009. Approximately two days after vaccination  the patient developed fever and chills with resolved overnight. The patient went running the next day and experienced chest pain that resolved with walking, but resumed when she returned running. Other reported symptoms included dyspnea and a sensation of a pounding regular heartbeat. The patient presented to an acute care clinic where an electrocardiogram was performed and was significant for incomplete right bundle branch block. The patient was sent to an emergency room for further evaluation. The patient was not hospitalized and recovered.
Age: 55.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Feeling abnormal, Injection site discharge, Injection site erythema, Injection site mass, Injection site pruritus
Clinical narrative: This case was received on 09-June-2009 from a consumer.  A male patient of unknown age received the following vaccination on 01-June-2009:  smallpox (trade name and manufacturer unknown).  NOTE:  Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination.  Eight days after vaccination, the patient reported to the ACAM2000 hotline a very large swollen, red and itchy area starting to expand from the vaccination site to outside the bandaged area.  He also reported a lump radiating from the vaccination site down his arm and yellowish liquid coming from the site.  Additional reactions reported were feeling "loopy" and heart palpitations.  He called a doctor who prescribed an antibiotic and BENADRYL for the itching and who referred him to an infectious disease doctor.  No additional information was provided.  Follow-up #1 received from a consumer on 16 June 2009.  The patient reported local pruritis beginning on Day 7 after vaccination.  By Day 8, his symptoms included increased local swelling, pain, drainage and red streaks radiating to axilla.  The patient was seen in the ER and prescribed CEPHALEXIN (1 PO, q 6 hours, duration not reported).  The patient reported taking the antibiotic for 2 days only.  The adverse event is reported to be resolving and much improved.  Based on the history provided, it is possible that the patient had cellulitis at the injection site.  No additional information is expected.  List of documents held by sender:  none.
Age: 55.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Injection site swelling, Palpitations
Clinical narrative: This case was received on 09-June-2009 from a consumer.  A male patient of unknown age received the following vaccination on 01-June-2009:  smallpox (trade name and manufacturer unknown).  NOTE:  Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination.  Eight days after vaccination, the patient reported to the ACAM2000 hotline a very large swollen, red and itchy area starting to expand from the vaccination site to outside the bandaged area.  He also reported a lump radiating from the vaccination site down his arm and yellowish liquid coming from the site.  Additional reactions reported were feeling "loopy" and heart palpitations.  He called a doctor who prescribed an antibiotic and BENADRYL for the itching and who referred him to an infectious disease doctor.  No additional information was provided.  Follow-up #1 received from a consumer on 16 June 2009.  The patient reported local pruritis beginning on Day 7 after vaccination.  By Day 8, his symptoms included increased local swelling, pain, drainage and red streaks radiating to axilla.  The patient was seen in the ER and prescribed CEPHALEXIN (1 PO, q 6 hours, duration not reported).  The patient reported taking the antibiotic for 2 days only.  The adverse event is reported to be resolving and much improved.  Based on the history provided, it is possible that the patient had cellulitis at the injection site.  No additional information is expected.  List of documents held by sender:  none.
Age: 55.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Feeling abnormal, Injection site discharge, Injection site erythema, Injection site mass, Injection site pain
Clinical narrative: This case was received on 09-June-2009 from a consumer.  A male patient of unknown age received the following vaccination on 01-June-2009:  smallpox (trade name and manufacturer unknown).  NOTE:  Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination.  Eight days after vaccination, the patient reported to the ACAM2000 hotline a very large swollen, red and itchy area starting to expand from the vaccination site to outside the bandaged area.  He also reported a lump radiating from the vaccination site down his arm and yellowish liquid coming from the site.  Additional reactions reported were feeling "loopy" and heart palpitations.  He called a doctor who prescribed an antibiotic and BENADRYL for the itching and who referred him to an infectious disease doctor.  No additional information was provided.  Follow-up #1 received from a consumer on 16 June 2009.  The patient reported local pruritis beginning on Day 7 after vaccination.  By Day 8, his symptoms included increased local swelling, pain, drainage and red streaks radiating to axilla.  The patient was seen in the ER and prescribed CEPHALEXIN (1 PO, q 6 hours, duration not reported).  The patient reported taking the antibiotic for 2 days only.  The adverse event is reported to be resolving and much improved.  Based on the history provided, it is possible that the patient had cellulitis at the injection site.  No additional information is expected.  List of documents held by sender:  none.
Age: 55.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Injection site pruritus, Injection site streaking, Injection site swelling, Palpitations
Clinical narrative: This case was received on 09-June-2009 from a consumer.  A male patient of unknown age received the following vaccination on 01-June-2009:  smallpox (trade name and manufacturer unknown).  NOTE:  Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination.  Eight days after vaccination, the patient reported to the ACAM2000 hotline a very large swollen, red and itchy area starting to expand from the vaccination site to outside the bandaged area.  He also reported a lump radiating from the vaccination site down his arm and yellowish liquid coming from the site.  Additional reactions reported were feeling "loopy" and heart palpitations.  He called a doctor who prescribed an antibiotic and BENADRYL for the itching and who referred him to an infectious disease doctor.  No additional information was provided.  Follow-up #1 received from a consumer on 16 June 2009.  The patient reported local pruritis beginning on Day 7 after vaccination.  By Day 8, his symptoms included increased local swelling, pain, drainage and red streaks radiating to axilla.  The patient was seen in the ER and prescribed CEPHALEXIN (1 PO, q 6 hours, duration not reported).  The patient reported taking the antibiotic for 2 days only.  The adverse event is reported to be resolving and much improved.  Based on the history provided, it is possible that the patient had cellulitis at the injection site.  No additional information is expected.  List of documents held by sender:  none.
Age: 27.0
Sex: M
Vaccine: FLUN3, FLUN3
Symptoms: Cough, Myalgia
Clinical narrative: Pt developed flu symptoms after given FLUMIST. He was on immune modulator - HUMIRA. Recovered completely with TAMIFLU and symptomatic treatment.
Age: 27.0
Sex: M
Vaccine: FLUN3, FLUN3
Symptoms: Influenza
Clinical narrative: Pt developed flu symptoms after given FLUMIST. He was on immune modulator - HUMIRA. Recovered completely with TAMIFLU and symptomatic treatment.
Age: 73.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Pain in extremity
Clinical narrative: Instant radiating pain at injection site.  Within an hour encompassed entire shoulder resulting in limited arm movement and usage.
Age: 73.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Immediate post-injection reaction, Injected limb mobility decreased, Injection site pain, Musculoskeletal pain, Nerve conduction studies
Clinical narrative: Instant radiating pain at injection site.  Within an hour encompassed entire shoulder resulting in limited arm movement and usage.
Age: 73.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Nuclear magnetic resonance imaging, X-ray
Clinical narrative: Instant radiating pain at injection site.  Within an hour encompassed entire shoulder resulting in limited arm movement and usage.
Age: 20.0
Sex: F
Vaccine: FLU(H1N1), FLU(H1N1)
Symptoms: Dizziness, Heart rate increased, Nausea, Tremor
Clinical narrative: Received H1N1 vaccine on 10/20/09 at 1445-1500 - feeling light headed and dizzy complained of nausea shaky BP 126/81 - 94-22 finger stick 88, 1515- HR at 190 1530 HR 101- went to Hospital and was given IVF, Zoloft. EKG done.
Age: 20.0
Sex: F
Vaccine: FLU(H1N1), FLU(H1N1)
Symptoms: Blood glucose normal, Dizziness, Electrocardiogram, Heart rate increased, Nausea
Clinical narrative: Received H1N1 vaccine on 10/20/09 at 1445-1500 - feeling light headed and dizzy complained of nausea shaky BP 126/81 - 94-22 finger stick 88, 1515- HR at 190 1530 HR 101- went to Hospital and was given IVF, Zoloft. EKG done.
Age: 20.0
Sex: F
Vaccine: FLU(H1N1), FLU(H1N1)
Symptoms: Tremor
Clinical narrative: Received H1N1 vaccine on 10/20/09 at 1445-1500 - feeling light headed and dizzy complained of nausea shaky BP 126/81 - 94-22 finger stick 88, 1515- HR at 190 1530 HR 101- went to Hospital and was given IVF, Zoloft. EKG done.
Age: 79.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Discomfort, Erythema, Insomnia, Oedema peripheral, Pain in extremity
Clinical narrative: Patient experienced severe soreness to arm with redness/swelling. Unable to sleep b/c of discomfort.
Age: 60.0
Sex: F
Vaccine: FLU3
Symptoms: Pain in extremity
Clinical narrative: Patients was administered on 10/13/09. Patient called pharmacy on 10/19/09 stating arm still in pain. She was told to call her primary care physician. I called patient at home on 10/23/09 her arm still was in pain and she still had not spoken to her physician. I informed her to call her physician again.
Age: 1.24
Sex: M
Vaccine: FLU(H1N1), FLU3
Symptoms: Urticaria
Clinical narrative: Child received 0.25 FLUZONE and 0.25 H1N1 vaccines simultaneous B legs. 10 min. later developed hives-trunk, leg. Waning hive after BENADRYL 3/4 tsp. 12.5/5 given PO. 10/27/09 PCP medical records received service date 10/24/09 Assessment: Hives. Patient developed hives on thighs, right shoulder, abdomen, 10 minutes after H1N1 vaccine.
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache, Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Patient complained of a headache for 2 days. Also complained of left arm being red, itchy and swollen about the size of her palm / hand. Advised patient to take Tylenol as directed for the headache, and Benadryl as directed for the itching. Advised patient to use cool compresses to arm and may try Hydrocortisone creams as directed.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Developed redness and swelling of right upper leg.
Age: 57.0
Sex: F
Vaccine: PPV
Symptoms: Blood culture negative, Cellulitis, Chills, Decreased appetite, Hyponatraemia
Clinical narrative: Pt had malaise and anorexia.  The next morning she had fever/chills, malaise, anorexia, mild nausea -- and this persisted 2 days after vaccination with 1 day of local redness, swelling, warmth, induration and pain of the injection site (left deltoid).  Seen in ED where she was found to have leukocytosis also.  Treated with vancomycin/unasyn for presumed cellulitis and over the next day her fever and chills and leukocytosis improved - as did her malaise.  But the redness/swelling persisted and the redness of her arm got worse.  Treated with vancomycin but feel that her reaction may have been a profound immune response to the vaccine.  Blood cultures negative.  skin intact.  12/01/09 and 12/29/09 DC summary for DOS 10/25/09-10/28/09 Final DX: cellulitis of upper arm, reaction to vaccine, hyponatremia, SIADH, leukocytosis and anemia. Pt c/o malaise, redness, tenderness, swelling at site of injection, anorexia/nausea and fever/chills. Upon physical examination, Pt had 12 cm erythematous indurated area of L upper arm, warm to touch. Pt was taking chemotherapy at the time of this event. WBC increased with a left shift.  TX:Vancomycin and Unasyn treatments started. Fever resolved during hospitalization.  Pt recommended to not take Pneumovax vaccine in the future due to potential allergic reaction. Pt discharged home in stable condition.
Age: 57.0
Sex: F
Vaccine: PPV
Symptoms: Immunisation reaction, Injection site erythema, Injection site induration, Injection site pain, Injection site warmth
Clinical narrative: Pt had malaise and anorexia.  The next morning she had fever/chills, malaise, anorexia, mild nausea -- and this persisted 2 days after vaccination with 1 day of local redness, swelling, warmth, induration and pain of the injection site (left deltoid).  Seen in ED where she was found to have leukocytosis also.  Treated with vancomycin/unasyn for presumed cellulitis and over the next day her fever and chills and leukocytosis improved - as did her malaise.  But the redness/swelling persisted and the redness of her arm got worse.  Treated with vancomycin but feel that her reaction may have been a profound immune response to the vaccine.  Blood cultures negative.  skin intact.  12/01/09 and 12/29/09 DC summary for DOS 10/25/09-10/28/09 Final DX: cellulitis of upper arm, reaction to vaccine, hyponatremia, SIADH, leukocytosis and anemia. Pt c/o malaise, redness, tenderness, swelling at site of injection, anorexia/nausea and fever/chills. Upon physical examination, Pt had 12 cm erythematous indurated area of L upper arm, warm to touch. Pt was taking chemotherapy at the time of this event. WBC increased with a left shift.  TX:Vancomycin and Unasyn treatments started. Fever resolved during hospitalization.  Pt recommended to not take Pneumovax vaccine in the future due to potential allergic reaction. Pt discharged home in stable condition.